China's SFDA Bans 300 Drug and Device Manufacturers
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State Food and Drug Administration shut down nearly 300 drug and device manufacturers as part of its nationwide campaign to increase compliance standards in pharmaceutical production, the drug watchdog said in a Dec. 3 press conference held by the State Council Information Office in Beijing